Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human erythropoietin to increase hemoglobin and reduce blood transfusion in femoral fracture patients
TCTR20230117005Phase 4Completed
- Sponsor
- Vajira Hospital
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of erythropoietin in anaemia, sponsored by Vajira Hospital. Started Apr 2021; status: completed.
02
Drugs
erythropoietin
03
Conditions
anaemia
Beyond the preview
Go deeper on TCTR20230117005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230117005.